Unique ID issued by UMIN | UMIN000014398 |
---|---|
Receipt number | R000016549 |
Scientific Title | A Prospective, Multi-center Investigation of the performance of Endo GIA Reinforced Reload with Tri-Staple Technology in Gastrectomy for Gastric Cancer |
Date of disclosure of the study information | 2014/06/27 |
Last modified on | 2017/03/11 22:49:03 |
A Prospective, Multi-center Investigation of the performance of Endo GIA Reinforced Reload with Tri-Staple Technology in Gastrectomy for Gastric Cancer
A Prospective, Multi-center Investigation of the performance of Endo GIA Reinforced Reload with Tri-Staple Technology in Gastrectomy for Gastric Cancer
A Prospective, Multi-center Investigation of the performance of Endo GIA Reinforced Reload with Tri-Staple Technology in Gastrectomy for Gastric Cancer
A Prospective, Multi-center Investigation of the performance of Endo GIA Reinforced Reload with Tri-Staple Technology in Gastrectomy for Gastric Cancer
Japan |
Gastric Cancer
Gastrointestinal surgery |
Malignancy
NO
The objective of this study is to assess the performance of a surgical stapling device, Endo GIA Reinforced Reload with Tri-Staple Technology, used in gastrectomy.
Safety,Efficacy
Incidence of postoperative duodenal stump leakage
Staple line hemostasis, any staple malformation, incidence of serosal injury, any additional suturing, amount of blood loss, duration of surgery, incidence of intraoperative and postoperative adverse events, duration of drain placement, duration of hospital stay
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1)Patients with gastric cancer planned to undergo open or laparoscopic (distal or total) gastrectomy with Roux-en-Y reconstruction using a surgical stapling device
2)Patients aged 20 years or older
3)Patients with no history of upper abdominal surgery (with the exception of laparoscopic cholecystectomy)
4)Patients with an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1
5)Patients with adequate functions of major organs
6)Patients who have provided written informed consent in person for participation in the study
1)Women who are pregnant or possibly pregnant, or breastfeeding
2)Patients receiving continuous systemic (oral or intravenous) steroid therapy
3)Patients with concurrent diabetes mellitus with poor control (HbA1c > 8.0%)
4)Patients with a history of allergy to nickel or chrome (a contraindication in IFU)
5)Patients with concurrent mental disorder or psychiatric symptoms judged to preclude participation in this study
6)Other patients judged by the investigator to be inappropriate as a subject of this study
100
1st name | |
Middle name | |
Last name | Kazunari Misawa |
Aichi Cancer Center Hospital
Department of Gastrointestinal Surgery
1-1 Kanokoden, Chikusa-ku, Nagoya-shi, Aichi Prefecture, 464- 8681
052-762-6111
misawakzn@aichi-cc.jp
1st name | |
Middle name | |
Last name | Kazunari Misawa |
Aichi Cancer Center Hospital
Department of Gastrointestinal Surgery
1-1 Kanokoden, Chikusa-ku, Nagoya-shi, Aichi Prefecture, 464- 8681
052-762-6111
misawakzn@aichi-cc.jp
Aichi Cancer Center Hospital, Department of Gastrointestinal Surgery
Covidien Japan Inc.
Profit organization
NO
愛知県がんセンター中央病院(愛知県)
神奈川県立がんセンター(神奈川県)
2014 | Year | 06 | Month | 27 | Day |
Unpublished
Main results already published
2014 | Year | 04 | Month | 28 | Day |
2014 | Year | 06 | Month | 30 | Day |
Prospective, multi-center, single-arm, observational registry study
2014 | Year | 06 | Month | 27 | Day |
2017 | Year | 03 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016549